Neuromuscular Plasticity in Response to Obesity: Effects of Mechanical Overload, Metabolic Disorders and Age
NCT ID: NCT04106570
Last Updated: 2023-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
92 participants
INTERVENTIONAL
2019-12-02
2023-06-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Modalities on Exercise Performance and Post-exercise Recovery of CrossFit® Athletes
NCT05985967
The Use of Repetitive Magnetic Stimulation for Strength Training of the Quadriceps Muscle
NCT00159367
Force Control in Chronic Obstructive Pulmonary Disease
NCT06871670
The Impact of Bed Rest, Aging and NMES on Skeletal Muscle
NCT05617222
Metformin and Muscle Recovery
NCT06185179
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The PLANEUROB research project is a physiological observational study comparing the respective effects of mechanical overload, metabolic disorders and age on torque production, fatigability and functional capacity in obese people. Subjects will have to perform a fatigue protocol, an adapted Margaria test and a 6 minutes walking test in one session. Blood samples, muscular ultrasound scanner and physical activity assessment will also be achieved.
Data will be analysed using LabChart 7.3 Pro software (ADInstrument, New South Wales, Australia), ImageJ (NIH Image, Bethesda, Maryland, USA) and Statistica 8.0 software (StatSoft, Inc.) and significance will be accepted at a two-sided alpha level of p\<.05. The normality and homogeneity of the variables will be checked respectively from a Shapiro- Wilk test and a Barlett test. If normality and homogeneity of the variables are verified, absolute values of variables (Torque, EMG, mean grey, etc.) will be compared using two factors (age x metabolic disorders) analyses of variance (ANOVA) with repeated measures. If analyses reveal a significant effect of any factor or interaction of factors, post-hoc Newman-Keuls tests will be performed to determine differences between the different conditions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
YOMH
Young obese metabolically healthy Description: Aged from 20 to 40 years old and with a glycemia \< 1g/l and a triglyceridemia \< 1,5g/l.
fatiguability of the knee extensors
fatiguability of the knee extensors (in N.m) measured with a dynamometer.
YOMD
Young obese with metabolic disorders
Description: Aged from 20 to 40 years old and with a glycemia \> 1g/l and a triglyceridemia \> 1,5g/l.
fatiguability of the knee extensors
fatiguability of the knee extensors (in N.m) measured with a dynamometer.
MAOMH
Middle-Age obese metabolically healthy
Description: Aged from 40 to 50 years old and with a glycemia \< 1g/l and a triglyceridemia \< 1,5g/l.
fatiguability of the knee extensors
fatiguability of the knee extensors (in N.m) measured with a dynamometer.
MAOMD
Middle-Age obese with metabolic disorders Description: Aged from 40 to 50 years old and with a glycemia \> 1g/l and a triglyceridemia \> 1,5g/l.
fatiguability of the knee extensors
fatiguability of the knee extensors (in N.m) measured with a dynamometer.
EOMH
Elderly obese metabolically healthy
Description: Aged from 50 to 70 years old and with a glycemia \< 1g/l and a triglyceridemia \< 1,5g/l.
fatiguability of the knee extensors
fatiguability of the knee extensors (in N.m) measured with a dynamometer.
EOMD
Elderly obese with metabolic disorders
Description: Aged from 50 to 70 years old and with a glycemia \> 1g/l and a triglyceridemia \> 1,5g/l.
fatiguability of the knee extensors
fatiguability of the knee extensors (in N.m) measured with a dynamometer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fatiguability of the knee extensors
fatiguability of the knee extensors (in N.m) measured with a dynamometer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject with a BMI greater than 30kg/m².
* Subject with a stable weight for at least 3 months before the start of the study.
* Subject capable and willing to comply with the protocol and willing to give informed consent in writing.
* Subject affiliated to a social security system.
Exclusion Criteria
* Subject with a medical contraindication to intense activity.
* Subject weighing more than 170kg, which may damage the dynamometer chair.
* Subject with a treatment that, in the investigator's opinion, may interfere with the evaluation of study criteria, period of exclusion from a previous clinical study.
* Subject who has received a total amount of compensation since the beginning of the calendar year, greater than 4500 euros (amount may change depending on the regulation).
* Subject with a linguistic or physiological disability to sign informed consent.
* Subject deprived of liberty by administrative of juridical decision, under guardianship or curatorship.
* Pregnant or breastfeeding women.
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AME2P Laboratory, Clermont Auvergne University
UNKNOWN
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yves Boirie
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Clermont Ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A00788-49
Identifier Type: OTHER
Identifier Source: secondary_id
RBHP 2019 BOIRIE 3 (Planeurob)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.